Loading…
The company plans to issue 960,000 shares at $3.125 per share.
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD) announced a private placement offering of up to $8.8 million. The biotechnology firm plans to issue 960,000 shares at a price of $3.125 per share.
The private placement will result in the company receiving gross proceeds of $8.8 million. Each share will be issued at a price of $3.125.
As of the latest available data, Cadrenal Therapeutics has a free float of 2,424,159 shares.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.